Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: SARS-CoV-2

Broad Institute & UBC Researchers Develop COVID-19 Tracking Tool to Help Identify Mutations by Geography

A research team from the Broad institute, the University of British Columbia and 4Fusion Genomics Corporation have developed an open, free public browser […]

Broad Institute & UBC Researchers Develop COVID-19 Tracking Tool to Help Identify Mutations by Geography
6 days ago
Share

No More ‘Fun in the Sun’ as COVID-19 Spikes in Jamaica While Nation’s Medical Association Suggests Ivermectin to Ministry of Health and Wellness

The Medical Association of Jamaica (MAJ) has apparently been doing their homework on the generic drug ivermectin and now have called […]

No More ‘Fun in the Sun’ as COVID-19 Spikes in Jamaica While Nation’s Medical Association Suggests Ivermectin to Ministry of Health and Wellness
1 week ago
Share

Monoclonal Antibodies Against MERS Coronavirus Show Promise in Phase 1 NIH-sponsored Trial

A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes Middle East […]

Monoclonal Antibodies Against MERS Coronavirus Show Promise in Phase 1 NIH-sponsored Trial
2 weeks ago
Share

Pharmacy Queues Growing in Bulgaria as Ivermectin is Made Available OTC

The drug Huvemek, which contains the active ingredient ivermectin, is of great interest in hundreds of pharmacies across the country, […]

Pharmacy Queues Growing in Bulgaria as Ivermectin is Made Available OTC
2 weeks ago
Share

University of Kansas Medical Center Seeks to Broaden Repertoire’ of COVID-19 treatments via NIH-based ACTIV-2 Clinical Trial

Although COVID-19 vaccines are now available for emergency use, that doesn’t preclude the desperate need for compelling, effective and safe […]

University of Kansas Medical Center Seeks to Broaden Repertoire’ of COVID-19 treatments via NIH-based ACTIV-2 Clinical Trial
3 weeks ago
Share

Update on South African Doctors’ Legal Action to Make Ivermectin Available as Prescription for COVID-19

A group of South African doctors has taken on South African drug regulator known as SAHPRA to make ivermectin more accessible […]

Update on South African Doctors’ Legal Action to Make Ivermectin Available as Prescription for COVID-19
3 weeks ago
Share

Tel Aviv Sourasky Medical Center Successfully Completes Phase 1 Study: 29 out of 30 Moderate-to-Severe COVID-19 Patients Recover in 3 to 5 Days thanks to EXO-CD24

A novel cancer drug known as EXO-CD24 developed and tested at Tel Aviv Sourasky Medical Center (Ichilov Hospital), demonstrates promising […]

Tel Aviv Sourasky Medical Center Successfully Completes Phase 1 Study 29 out of 30 Moderate-to-Severe COVID-19 Patients Recover in 3 to 5 Days thanks to EXO-CD24
4 weeks ago
Share

Rwanda Accepts Favipiravir for Early Onset Mild COVID-19 Adding to a Growing List of Nations

The eastern African nation of Rwanda appears to be joining dozens of others nations worldwide and accepting Favipiravir as a […]

Rwanda Accepts Favipiravir for Early Onset Mild COVID-19 Adding to a Growing List of Nations`
4 weeks ago
Share

UCI Heads Study Investigating NeuroRX’s ZYESAMI™ (aviptadil) Investigating Ability to Reduce Progression to Critical COVID-19

During the pandemic, TrialSite has reported multiple times on the potential for NeuroRX’s RLF-100 (aviptadil) currently under investigation and accessible […]

UCI Heads Study Investigating NeuroRX’s ZYESAMI™ (aviptadil) Investigating Ability to Reduce Progression to Critical COVID-19
4 weeks ago
Share

China & RTP’s Brii Biosciences Selected by NIAID for Combo Monoclonal Antibody Clinical Trial Targeting COVID-19

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), continues to invest […]

China & RTP’s Brii Biosciences Selected by NIAID for Combo Monoclonal Antibody Clinical Trial Targeting COVID-19
4 weeks ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.